198 related articles for article (PubMed ID: 29266176)
1. Bone mineral density in children with acute lymphoblastic leukemia.
Inaba H; Cao X; Han AQ; Panetta JC; Ness KK; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Cheng C; Pui CH; Relling MV; Kaste SC
Cancer; 2018 Mar; 124(5):1025-1035. PubMed ID: 29266176
[TBL] [Abstract][Full Text] [Related]
2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
3. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
[TBL] [Abstract][Full Text] [Related]
4. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
5. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
6. Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.
Kaushik A; Bansal D; Khandelwal N; Trehan A; Marwaha RK
Indian Pediatr; 2009 Mar; 46(3):245-8. PubMed ID: 19213989
[TBL] [Abstract][Full Text] [Related]
7. Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia.
Browne EK; Zhou Y; Chemaitilly W; Panetta JC; Ness KK; Kaste SC; Cheng C; Relling MV; Pui CH; Inaba H
Cancer; 2018 Nov; 124(21):4248-4259. PubMed ID: 30358906
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study.
Gurney JG; Kaste SC; Liu W; Srivastava DK; Chemaitilly W; Ness KK; Lanctot JQ; Ojha RP; Nottage KA; Wilson CL; Li Z; Robison LL; Hudson MM
Pediatr Blood Cancer; 2014 Jul; 61(7):1270-6. PubMed ID: 24585546
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development.
Kaste SC; Jones-Wallace D; Rose SR; Boyett JM; Lustig RH; Rivera GK; Pui CH; Hudson MM
Leukemia; 2001 May; 15(5):728-34. PubMed ID: 11368432
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.
Geneviève N; Mojgan Y; Nahid Y; Vincenzo F; Simon G; Daniel S; Maja K; Nathalie A; Despoina M
J Bone Miner Res; 2024 Mar; 39(2):130-138. PubMed ID: 38477791
[TBL] [Abstract][Full Text] [Related]
11. Changes in pediatric DXA measures of musculoskeletal outcomes and correlation with quantitative CT following treatment of acute lymphoblastic leukemia.
Mostoufi-Moab S; Kelly A; Mitchell JA; Baker J; Zemel BS; Brodsky J; Long J; Leonard MB
Bone; 2018 Jul; 112():128-135. PubMed ID: 29679731
[TBL] [Abstract][Full Text] [Related]
12. Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms.
Guo CY; Halton JM; Barr RD; Atkinson SA
Oncol Rep; 2004 Jan; 11(1):185-9. PubMed ID: 14654924
[TBL] [Abstract][Full Text] [Related]
13. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
14. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation.
Mostoufi-Moab S; Brodsky J; Isaacoff EJ; Tsampalieros A; Ginsberg JP; Zemel B; Shults J; Leonard MB
J Clin Endocrinol Metab; 2012 Oct; 97(10):3584-92. PubMed ID: 22865901
[TBL] [Abstract][Full Text] [Related]
16. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.
te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Uitterlinden AG; Hop WC; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2010 May; 95(5):752-9. PubMed ID: 20015871
[TBL] [Abstract][Full Text] [Related]
19. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
